1. Home
  2. NOTV vs VVOS Comparison

NOTV vs VVOS Comparison

Compare NOTV & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.34

Market Cap

12.7M

Sector

Health Care

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.28

Market Cap

15.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
VVOS
Founded
1974
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7M
15.1M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
NOTV
VVOS
Price
$0.34
$1.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$1.50
$6.25
AVG Volume (30 Days)
549.0K
88.8K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
49.64
80.07
EPS
N/A
N/A
Revenue
$547,656,000.00
$15,031,000.00
Revenue This Year
$5.28
$31.42
Revenue Next Year
$5.42
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
511.19
8.91
52 Week Low
$0.25
$1.28
52 Week High
$3.35
$7.40

Technical Indicators

Market Signals
Indicator
NOTV
VVOS
Relative Strength Index (RSI) 45.38 32.01
Support Level $0.26 N/A
Resistance Level $0.65 $1.88
Average True Range (ATR) 0.05 0.12
MACD 0.02 -0.00
Stochastic Oscillator 38.75 6.25

Price Performance

Historical Comparison
NOTV
VVOS

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: